Anfibatide Preserves Blood–Brain Barrier Integrity by Inhibiting TLR4/RhoA/ROCK Pathway After Cerebral Ischemia/Reperfusion Injury in Rat

[1]  Ye Li,et al.  Dynamic Effects of Ioversol on the Permeability of the Blood-Brain Barrier and the Expression of ZO-1/Occludin in Rats , 2019, Journal of Molecular Neuroscience.

[2]  A. Sporbert,et al.  Tight junction proteins at the blood–brain barrier: far more than claudin-5 , 2019, Cellular and Molecular Life Sciences.

[3]  Zhiping Hu,et al.  HSPB8 over‐expression prevents disruption of blood–brain barrier by promoting autophagic flux after cerebral ischemia/reperfusion injury , 2018, Journal of neurochemistry.

[4]  Dan Liu,et al.  Carotid thickness and atherosclerotic plaque stability, serum inflammation, serum MMP-2 and MMP-9 were associated with acute cerebral infarction , 2018, Experimental and therapeutic medicine.

[5]  Zhigang Chen,et al.  The Role of VE-cadherin in Blood-brain Barrier Integrity under Central Nervous System Pathological Conditions , 2018, Current neuropharmacology.

[6]  L. D. de Vries,et al.  Early Prediction of Hypoxic-Ischemic Brain Injury by a New Panel of Biomarkers in a Population of Term Newborns , 2018, Oxidative medicine and cellular longevity.

[7]  P. Tsao,et al.  MicroRNA-Mediated Therapy Modulating Blood–Brain Barrier Disruption Improves Vascular Cognitive Impairment , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[8]  Tianfu Wang,et al.  Autophagy- and MMP-2/9-mediated Reduction and Redistribution of ZO-1 Contribute to Hyperglycemia-increased Blood–Brain Barrier Permeability During Early Reperfusion in Stroke , 2018, Neuroscience.

[9]  J. Piontek,et al.  Reversible opening of the blood-brain barrier by claudin-5-binding variants of Clostridium perfringens enterotoxin's claudin-binding domain. , 2018, Biomaterials.

[10]  J. Klopfenstein,et al.  Prevention of the Severity of Post-ischemic Inflammation and Brain Damage by Simultaneous Knockdown of Toll-like Receptors 2 and 4 , 2018, Neuroscience.

[11]  H. Shin,et al.  Pretreatment with Shuanghe-Tang Extract Attenuates Postischemic Brain Injury and Edema in a Mouse Model of Stroke: An Analysis of Medicinal Herbs Listed in Dongui Bogam , 2018, Oxidative medicine and cellular longevity.

[12]  Zhiqiang Ma,et al.  Focusing on claudin-5: A promising candidate in the regulation of BBB to treat ischemic stroke , 2017, Progress in Neurobiology.

[13]  Lan-lan Zhou,et al.  Platelet glycoprotein receptor Ib blockade ameliorates experimental cerebral ischemia–reperfusion injury by strengthening the blood–brain barrier function and anti-thrombo-inflammatory property , 2017, Brain, Behavior, and Immunity.

[14]  M. Aschner,et al.  Role of matrix metalloproteinase-2/9 (MMP2/9) in lead-induced changes in an in vitro blood-brain barrier model , 2017, International journal of biological sciences.

[15]  Jie Ying Gao,et al.  MicroRNA-1906, a Novel Regulator of Toll-Like Receptor 4, Ameliorates Ischemic Injury after Experimental Stroke in Mice , 2017, The Journal of Neuroscience.

[16]  M. Sofroniew,et al.  Astrocytic tight junctions control inflammatory CNS lesion pathogenesis , 2017, The Journal of clinical investigation.

[17]  Sheng-Yong Luo,et al.  Anfibatide protects against rat cerebral ischemia/reperfusion injury via TLR4/JNK/caspase‐3 pathway , 2017, European journal of pharmacology.

[18]  M. Cvetanovic,et al.  Inhibition of colony-stimulating factor 1 receptor early in disease ameliorates motor deficits in SCA1 mice , 2017, Journal of Neuroinflammation.

[19]  C. Fontes-Ribeiro,et al.  Extended-access methamphetamine self-administration elicits neuroinflammatory response along with blood-brain barrier breakdown , 2017, Brain, Behavior, and Immunity.

[20]  Yunliang Guo,et al.  Picroside II protects the blood-brain barrier by inhibiting the oxidative signaling pathway in cerebral ischemia-reperfusion injury , 2017, PloS one.

[21]  Jing Zhao,et al.  AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung Microvascular Endothelial Permeability through Activation of Rho Signaling Pathway and Phosphorylation of VE-Cadherin , 2017, Mediators of inflammation.

[22]  Xiaoning Han,et al.  Cerebroprotection by the neuronal PGE2 receptor EP2 after intracerebral hemorrhage in middle-aged mice , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  Sung Hoon Baik,et al.  Annexin A1 restores Aβ1‐42‐induced blood–brain barrier disruption through the inhibition of RhoA‐ROCK signaling pathway , 2016, Aging cell.

[24]  L. Cheng,et al.  Acid fibroblast growth factor preserves blood-brain barrier integrity by activating the PI3K-Akt-Rac1 pathway and inhibiting RhoA following traumatic brain injury. , 2017, American journal of translational research.

[25]  X. Zheng,et al.  Therapeutic efficacy of the platelet glycoprotein Ib antagonist anfibatide in murine models of thrombotic thrombocytopenic purpura. , 2016, Blood advances.

[26]  U. Bayraktutan,et al.  Suppression of PKC-α attenuates TNF-α-evoked cerebral barrier breakdown via regulations of MMP-2 and plasminogen-plasmin system. , 2016, Biochimica et biophysica acta.

[27]  A. Hartz,et al.  Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  Luyong Zhang,et al.  Nafamostat mesilate protects against acute cerebral ischemia via blood–brain barrier protection , 2016, Neuropharmacology.

[29]  P. Alvito,et al.  Characterization of in vitro effects of patulin on intestinal epithelial and immune cells. , 2016, Toxicology letters.

[30]  R. Keep,et al.  Rapid endothelial cytoskeletal reorganization enables early blood–brain barrier disruption and long-term ischaemic reperfusion brain injury , 2016, Nature Communications.

[31]  K. Jin,et al.  Limb Ischemic Perconditioning Attenuates Blood-Brain Barrier Disruption by Inhibiting Activity of MMP-9 and Occludin Degradation after Focal Cerebral Ischemia. , 2015, Aging and disease.

[32]  Xiufen Zheng,et al.  Cinnamaldehyde inhibits inflammation and brain damage in a mouse model of permanent cerebral ischaemia , 2015, British journal of pharmacology.

[33]  K. Tsai,et al.  Deletion of Nuclear Localizing Signal Attenuates Proinflammatory Activity of Prothymosin-Alpha and Enhances Its Neuroprotective Effect on Transient Ischemic Stroke , 2016, Molecular Neurobiology.

[34]  A. Tsiskaridze,et al.  Correlation between MMP-9 and extracellular cytokine HMGB1 in prediction of human ischemic stroke outcome. , 2014, Biochimica et biophysica acta.

[35]  W. Xia,et al.  Adjudin protects against cerebral ischemia reperfusion injury by inhibition of neuroinflammation and blood-brain barrier disruption , 2014, Journal of Neuroinflammation.

[36]  H. Ni,et al.  Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis , 2013, Thrombosis and Haemostasis.

[37]  Ping Cai,et al.  Recombinant ADAMTS13 reduces tissue plasminogen activator‐induced hemorrhage after stroke in mice , 2013, Annals of neurology.

[38]  S. Rohrbach,et al.  Hypoxia–reoxygenation‐induced endothelial barrier failure: role of RhoA, Rac1 and myosin light chain kinase , 2013, The Journal of physiology.

[39]  R. Zukin,et al.  Epigenetic Mechanisms in Stroke and Epilepsy , 2013, Neuropsychopharmacology.

[40]  Y. Cheng,et al.  Erythropoietin promotes axonal regeneration after optic nerve crush in vivo by inhibition of RhoA/ROCK signaling pathway , 2012, Neuropharmacology.

[41]  V. Janardhan,et al.  Blood–brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke , 2012, Neurology.

[42]  H. Hara,et al.  A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator , 2012, Neuroscience.

[43]  C. Borlongan,et al.  Breaking the barrier in stroke: what should we know? A mini-review. , 2012, Current pharmaceutical design.

[44]  John H. Zhang,et al.  Inhibition of Rho kinase by hydroxyfasudil attenuates brain edema after subarachnoid hemorrhage in rats , 2012, Neurochemistry International.

[45]  Derek R Van Lonkhuyzen,et al.  GEF-H1-RhoA signaling pathway mediates LPS-induced NF-κB transactivation and IL-8 synthesis in endothelial cells. , 2012, Molecular immunology.

[46]  A. Zechariah,et al.  Increased Blood–Brain Barrier Permeability and Brain Edema After Focal Cerebral Ischemia Induced by Hyperlipidemia: Role of Lipid Peroxidation and Calpain-1/2, Matrix Metalloproteinase-2/9, and RhoA Overactivation , 2011, Stroke.

[47]  F. Thong,et al.  Adiponectin increases LPL activity via RhoA/ROCK-mediated actin remodelling in adult rat cardiomyocytes. , 2011, Endocrinology.

[48]  S. Ding,et al.  Role of Rho Kinase in Microvascular Damage Following Cerebral Ischemia Reperfusion in Rats , 2011, International journal of molecular sciences.

[49]  U. Knaus,et al.  The Low Molecular Weight GTPase RhoA and Atypical Protein Kinase Cζ Are Required for TLR2-Mediated Gene Transcription1 , 2004, The Journal of Immunology.

[50]  Shuang Huang,et al.  IL-1 Receptor-Associated Kinase and Low Molecular Weight GTPase RhoA Signal Molecules Are Required for Bacterial Lipopolysaccharide-Induced Cytokine Gene Transcription1 , 2002, The Journal of Immunology.

[51]  M. Fini,et al.  Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood–Brain Barrier and White Matter Components after Cerebral Ischemia , 2001, The Journal of Neuroscience.

[52]  P. Godowski,et al.  Toll-like receptor 2–mediated NF-κB activation requires a Rac1-dependent pathway , 2000, Nature Immunology.

[53]  G. Rosenberg,et al.  Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. , 1998, Stroke.

[54]  L. Boréus.  Use of human fetal ileum for evaluation of smooth muscle effects of narcotic analgesics. , 1971, European journal of pharmacology.